UnitedHealthcare Program Will Bar Copay Coupons For Six Specialty Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
The drugs targeted by the policy taking effect Jan. 1 are: Extavia and Gilenya for multiple sclerosis, Cellcept for transplant patients, Humira for rheumatoid arthritis, Crohn’s disease and psoriasis and Victrelis and PegIntron for hepatitis C.